Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption.

about

The influence of biomechanical properties and cannabinoids on tumor invasion Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo.

P2860

Q30315036-61688F85-E43F-4CEE-B07C-B2D36F1C4CDD Q38737351-772068C7-13EC-4C07-AA9B-9929D9FDEE35

P2860

Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption.

Item

http://www.wikidata.org/entity/Q38914267

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Targeting cannabinoid receptor ...... n and cytoskeleton disruption.

@en

type

Item

label

Targeting cannabinoid receptor ...... n and cytoskeleton disruption.

@en

prefLabel

Targeting cannabinoid receptor ...... n and cytoskeleton disruption.

@en

P1476

Targeting cannabinoid receptor ...... n and cytoskeleton disruption.

@en

P2093

G David Roodman

http://www.w3.org/2001/XMLSchema#string

Haizi Cheng

http://www.w3.org/2001/XMLSchema#string

Lirong Wang

http://www.w3.org/2001/XMLSchema#string

Qin Tong

http://www.w3.org/2001/XMLSchema#string

Rentian Feng

http://www.w3.org/2001/XMLSchema#string

Suzanne Lentzsch

http://www.w3.org/2001/XMLSchema#string

Xiang-Qun Xie

http://www.w3.org/2001/XMLSchema#string

Zhaojun Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of activator protein-1, NF-kappa B, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Distinct expression profiles of the peripheral cannabinoid receptor in lymphoid tissues depending on receptor activation status

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs

Following a TRAIL: update on a ligand and its five receptors

Molecular characterization of a peripheral receptor for cannabinoids

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

P304

1796-1806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MC.22251

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271709914

http://www.w3.org/2001/XMLSchema#string

P698

25640641

http://www.w3.org/2001/XMLSchema#string

P921

P932

4504841

http://www.w3.org/2001/XMLSchema#string

Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption.

about

P2860

P2860

Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932